PRESTIGE BRAND HOLDINGS INC

NYSE: PBH (Prestige Consumer Healthcare In)

Last update: 14 Jul, 3:18AM

70.34

0.13 (0.19%)

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bullish Bearish
Drug Manufacturers - Specialty & Generic (Global) Bullish Bearish
Stock Prestige Consumer Healthcare In - -

Stockmoo Score

2.3

Similar Stocks

Stock Market Cap DY P/E P/B
PBH 3 B - 16.87 2.13
ELAN 7 B - - 1.05
ZTS 80 B 0.92% 33.23 16.23
TAK 41 B 4.50% 44.78 0.890
HLN 39 B 1.76% 28.80 1.96
RDY 12 B 0.60% 18.01 4.02

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Core
52 Weeks Range
56.34 (-19%) — 75.31 (7%)
Price Target Range
80.00 (13%) — 93.00 (32%)
High 93.00 (DA Davidson, 32.22%) Buy
Median 86.50 (22.97%)
Low 80.00 (Canaccord Genuity, 13.73%) Buy
Average 86.50 (22.97%)
Total 2 Buy
Avg. Price @ Call 67.23
Firm Date Target Price Call Price @ Call
DA Davidson 21 Jun 2024 93.00 (32.21%) Buy 69.40
16 May 2024 65.00 (-7.59%) Hold 64.98
Canaccord Genuity 21 May 2024 80.00 (13.73%) Buy 65.05

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria